Clinical trial
Rapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children
NCT03175692 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 14, 2017
- Completion date
- May 31, 2020
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute disease, congenital metabolic disorder